Long-Term Cardiovascular Effects of Medications for Attention-Deficit/Hyperactivity Disorder-Balancing Benefits and Risks of Treatment

被引：3
|
作者：
Cortese, Samuele [1 ,2 ,3 ,4 ]
Fava, Cristiano [5 ,6 ]
机构：
[1] Univ Southampton, Fac Environm & Life Sci, Ctr Innovat Mental Hlth, Sch Psychol, Highfield Campus,Bldg 44, Southampton SO17 1BJ, England
[2] Solent NHS Trust, Southampton, England
[3] Univ Southampton, Fac Med, Sch Clin & Expt Sci, Southampton, England
[4] NYU, NYU Langone, Hassenfeld Childrens Hosp, Child Study Ctr, New York, NY USA
[5] Univ Verona, Dept Med, Gen Med & Hypertens Unit, Verona, Italy
[6] Lund Univ, Clin Res Ctr, Dept Clin Sci, Malmo, Sweden
来源：
JAMA PSYCHIATRY | 2024年 / 81卷 / 02期
关键词：
METHYLPHENIDATE; ADOLESCENTS; CHILDREN; ADHD;
D O I：
10.1001/jamapsychiatry.2023.4126
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：123 / 124
页数：2
相关论文
共 50 条
  • [1] Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
    Hammerness, Paul G.
    Karampahtsis, Chris
    Babalola, Ronke
    Alexander, Mark E.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 543 - 551
  • [2] Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases
    Zhang, Le
    Li, Lin
    Andell, Pontus
    Garcia-Argibay, Miguel
    Quinn, Patrick D.
    D'Onofrio, Brian M.
    Brikell, Isabell
    Kuja-Halkola, Ralf
    Lichtenstein, Paul
    Johnell, Kristina
    Larsson, Henrik
    Chang, Zheng
    [J]. JAMA PSYCHIATRY, 2024, 81 (02) : 178 - 187
  • [3] Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/ Hyperactivity Disorder (ADHD)
    Alexander, G. Caleb
    Moore, Thomas J.
    Brass, Eric P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (19) : 1883 - 1885
  • [4] Getting to Long-Term Effectiveness and Safety of Attention-deficit Hyperactivity Disorder Medications
    Beau-Lejdstrom, Raphaelle
    Zito, Julie Magno
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (04) : 610 - 612
  • [5] Long-term academic outcomes of attention-deficit hyperactivity disorder and effects of treatment
    Hodgkins, Paul
    Kahle, Jennifer
    Kewley, Geoff
    Madhoo, Manisha
    Arnold, L. Eugene
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S231 - S232
  • [6] Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
    Holt, Anders
    Strange, Jarl E.
    Rasmussen, Peter Vibe
    Nouhravesh, Nina
    Nielsen, Sebastian Kinnberg
    Sindet-Pedersen, Caroline
    Fosbol, Emil Loldrup
    Kober, Lars
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    McGettigan, Patricia
    Schou, Morten
    Lamberts, Morten
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (19) : 1870 - 1882
  • [7] Long-term prognosis in attention-deficit/hyperactivity disorder
    Mannuzza, S
    Klein, RG
    [J]. CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2000, 9 (03) : 711 - +
  • [8] Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder
    Wilens, Timothy E.
    Newcorn, Jeffrey H.
    Kratochvil, Christopher J.
    Gao, Haitao
    Thomason, Christine K.
    Rogers, Ann K.
    Feldman, Peter D.
    Levine, Louise R.
    [J]. JOURNAL OF PEDIATRICS, 2006, 149 (01): : 112 - 119
  • [9] Long-term treatment effects of atomoxetine in adults with attention-deficit/hyperactivity disorder (ADHD)
    Michelson, D
    Adler, L
    Spencer, T
    Milton, D
    Jones, D
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S458 - S458
  • [10] The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder
    Hazell, Philip
    [J]. CURRENT OPINION IN PSYCHIATRY, 2011, 24 (04) : 286 - 290
12345